Combined Therapeutics Inc

Combined Therapeutics has developed a unique modified mRNA platform which targets protein expression to specific tissues while reducing off target effects. Together with our partners, we are committed to using our platform to protect vulnerable populations from global infectious disease threats as well as to cure cancer.